Signed the informed consent | Screening
|
Inclusion and Exclusion criteria | Screening
|
General information, History of disease | Screening
|
Physical examination, TCM syndrome | Enrollment
/Baseline
/The 4th week of the treatment
/The 8th week of the treatment
/Completed
|
HbA1c, 24h urinary microalbumin | Screening
/Baseline
/Completed
|
Fasting blood glucose, Blood fat, Blood routine tests, Urine routine tests, Liver function tests, Renel function tests | Baseline
/The 4th week of treatment
/Completed
|
Serum FFA tests, ECG | Baseline
/Completed
|
Check for allocation of the madicine | Baseline
/The 4th week of treatment
/The 8th week of treatment
|
Effect assessmen | The 4th week of the treatment
/The 8th week of the treatment
/Completed
|
Eligible participant has to fullfill all of the following items | / / / / / / |
Anyone with one of following items or more should be excluded: |
- General Information
- History of present illness
- History of disease
- Family history of diabetes
- History of drug allergy
- Physical Examination
- Fasting Blood Glucose
- HbA1c
- blood Fat
- Quantitative test of 24h urinary protein
- Blood Routine Tests
- Urine Routine Tests
- Liver Function Tests
- Renel Function Tests
- Electrocardiogram
- Serum FFA tests
- TCM syndrome scores
- History of diabetes drug therapy
- Combined medication for other diseases
- Treatment of the studyed drugs
Date of birth | 1964-10-23 yyyy-mm-dd |
Age | 53 Years |
Diabetes | |
Type of Diabetes | Type II
|
Duration of the diabetes | 1 年 |
Diabetic Kidney Disease | |
Diagnosed to be diabetic kidney disease | 2017-09-24 yyyy-mm-dd |
Duration of the diabetic kidney disease | 0 年 |
Medication therapy or not | No
|
Disease name |
|
Does it keep to continue | |
Date of starting | yyyy-mm-dd |
Ending time | yyyy-mm-dd |
Disease name |
|
Does it continue to now | |
Date of starting | yyyy-mm-dd |
Ending time | yyyy-mm-dd |
Disease name |
|
Does it contimue to now | |
Date of starting | yyyy-mm-dd |
Ending time | yyyy-mm-dd |
Disease name |
|
Does it continue | |
Date of starting | yyyy-mm-dd |
Ending time | yyyy-mm-dd |
Researcher signature |
|
Date | yyyy-mm-dd |
Is/was there anyone with diabetes in your family? | No
|
Did you experienced any drug allergy? | No
|
Namy of the drug to be allergied |
|
Date of drug allergy happened | yyyy-mm-dd/mm-dd |
Current status |
|
Systolic pressure (SP) | 120 mmHg |
Diastolic pressure | 75 mmHg |
Temperature | 36.5 degree Celsius |
Pulse | 70 次/分 |
Breath | 20 次/分 |
Fasting blood glucos concentration | 5.78 mmol/L |
Date of test | 2017-09-24 yyyy-mm-dd |
HbA1c | 5.6 % |
Date of test | 2017-09-24 yyyy-mm-dd |
Triglycerides | 0.56 mmol/L |
Total cholesterol | 2.64 mmol/L |
High density lipoprotein cholesterol | 1.22 mmol/L |
Low density lipoprotein cholesterol | 1.26 mmol/L |
Date of examination | 2017-09-24 yyyy-mm-dd |
24h urinary albumin | 247.1 mg/24h |
24h urinary microalbumin | 77.5 mg/24h |
Hb | 145 g/L |
RBC | 4.83 X10*12/L |
WBC | 5.18 X10*9/L |
PLT | 94 X10*9/L |
78.7 % |
|
14.9 % |
|
Date of test | 2017-09-24 |
Urine protein | Negative
|
Urine red cell | Negative
|
Urine WBC | Positive+
|
Urine glucos | Negative
|
KET | Negative
|
SG | 1.021 |
Date of test | 2017-09-24 yyyy-mm-dd |
ALT | 17 IU/L |
AST | 19 IU/L |
Serum albumin | 51.3 g/L |
Date of test | 2017-09-24 yyyy-mm-dd |
Blood urea | 4.90 mmol/L |
SCr | 69 μmol/L |
Blood uric acid | 355 μmol/L |
eGFR | 93.5 ml/min/1.73m2 |
Date of test | 2017-09-24 yyyy-mm-dd |
ECG | Normal
|
Description for the abnormal findings |
|
Date of examination | 2017-09-24 yyyy-mm-dd |
Serum FFA tests | 无 |
Soreness and weakness of waist and knees | |
Lack of sexuality | |
Intolerance of cold and cold limbs | |
Mental sluggishness | |
Frequent urination at night | |
Lower Limb Edema | |
Shortness of breath when moving | |
Alopecia and shaken teeth | |
Tongue characteristics | |
Tongue coating colour and characters | |
Pause profile | |
Description in detail |
|
Doctor signature |
|
Date | yyyy-mm-dd |
Insulin | |
Dose | IU |
Date of using | yyyy-mm-dd |
Metformin drugs | |
Name of drug |
|
Dose | mg |
Date of use the drug | yyyy-mm-dd |
Sulfonylureas | |
Name of the drug |
|
Dose | mg |
Other reduce surgur drugs | |
Name of drug |
|
Dose |
|
Was there any combination use drug? | |
Name of the drug |
|
Approch of using the drug |
|
Date of starting use | yyyy-mm-dd |
Date of completed using | yyyy-mm-dd |
Reason of using |
|
Name of the drug |
|
Approch of using the drug |
|
Date of starting use | yyyy-mm-dd |
Date of completed using | yyyy-mm-dd |
Reason of using |
|
Number |
|
Dose | 袋/次 |
Frequency | 次/天 |
|
- TCM syndrome
- Fasting Blood Glucose
- blood lipids
- Blood Routine Tests
- Urine Routine Tests
- Liver Function Tests
- Renel Function Tests
- Treatment of studyed drugs
- Adverse events
Soreness and weakness of waist and knees | Moderate soreness and weakness of waist and knees
|
Lack of sexuality | No
|
Intolerance of cold and cold limbs | Slight intolerance of cold
|
Mental sluggishness | General
|
Frequent urination at night | Twice at night
|
Lower Limbs Edema | Slight Lower Limbs Edema
|
Shortness of breath when moving | No
|
Alopecia and shaken teeth | Dry hair and shaken teeth
|
Tongue characteristics | Light white
|
Tongue coating colour and characters | White tongue coating with water
|
Pause profile | Deep, thin, slow
|
Description in detail |
|
Doctor signature | 秦鑫 |
Date | 2017-10-24 yyyy-mm-dd |
Systolic pressure (SP) | 120 mmHg |
Diastolic pressure | 75 mmHg |
Temperature | 36 degree Celsius |
Pulse | 78 次/分 |
Breath | 24 次/分 |
Doctor signature | 秦鑫 |
Date | 2017-10-24 yyyy-mm-dd |
Fasting blood glucose | 4.89 mmol/L |
Date of test | 2017-10-24 yyyy-mm-dd |
Triglycerides | 0.60 mmol/L |
Total cholesterol | 2.68 mmol/L |
High density lipoprotein cholesterol | 1.11 mmol/L |
Low density lipoprotein cholesterol | 1.33 mmol/L |
Date of examination | 2017-10-24 yyyy-mm-dd |
Hb | 141 g/L |
RBC | 4.81 X10*12/L |
WBC | 4.55 X10*9/L |
PLT | 116 X10*9/L |
Neutrophile granulocyte | 66.2 % |
Lymphocyte | 23.7 % |
Date of test | 2017-10-24 |
Urine protein | Negative
|
Urine red cell | Negative
|
Urine WBC | Positive+++
|
Urine glucos | Negative
|
KET | Negative
|
SG | 1.007 |
Date of test | 2017-10-24 yyyy-mm-dd |
ALT | 21 IU/L |
AST | 22 IU/L |
Serum albumin | 47.7 g/L |
Date of test | 2017-10-24 yyyy-mm-dd |
Blood urea | 4.90 mmol/L |
SCr | 71 μmol/L |
Blood uric acid | 354 μmol/L |
Estimated glomerular filtration rate ( eGFR) | 84 ml/min/1.73m*2 |
Date of test | 2017-10-24 yyyy-mm-dd |
Date of using the drug | 2017-09-24 yyyy-mm-dd |
Dose in total | 2 袋/天 |
Weeks of medication | 4 周 |
Adverse events | No
|
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-10-24 yyyymmdd |
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-10-24 yyyymmdd |
Severe Adverse Event | |
Type of the report | |
Date of report | yyyy-mm-dd-hh-min. |
Name of the event |
|
SAE situation | |
Time of the adverse event occur | yyyy-mm-dd-hh-min. |
Severity of SAE | |
Measure for the original treatment | |
Outcome of the SAE | |
Relationship between treatment and SAE | |
Treatment in detail |
|
Reporting person |
|
Doctor signature | 秦鑫 |
Date | 2017-10-24 yyy-mm-dd |
Soreness and weakness of waist and knees | Moderate soreness and weakness of waist and knees
|
Lack of sexuality | No
|
Intolerance of cold and cold limbs | Slight intolerance of cold
|
Mental sluggishness | General
|
Frequent urination at night | Twice at night
|
Lower Limbs Edema | Slight Lower Limbs Edema
|
Shortness of breath when moving | Shortness of breath when walking
|
Alopecia and shaken teeth | Mat hair and shaken teeth
|
Tongue characteristics | Light white
|
Tongue coating colour and characters | White tongue coating with water
|
Pause profile | Deep, thin and slow
|
Description in detail |
|
Doctor signature | 秦鑫 |
Date | 2017-11-24 yyyy-mm-dd |
Systolic pressure (SP) | 120 mmHg |
Diastolic pressure | 80 mmHg |
Temperature | 36.8 degree Celsius |
Pulse | 70 次/分 |
Breath | 22 次/分 |
Doctor signature | 秦鑫 |
Date | 2017-11-24 yyyy-mm-dd |
Date of using the drug | 2017-09-24 yyyy-mm-dd |
Dose in total | 2 袋/天 |
Weeks of medication | 8 周 |
Adverse events | No
|
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-11-24 yyyymmdd |
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-11-24 yyyymmdd |
Date received at DCC | yyyymmdd |
Report type | |
Name of this event |
|
SAE start date | yyyymmdd |
SAE stop date | yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below |
|
Name of the recorder |
|
Data | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-11-24 yyyymmdd |
- TCM syndrome scores
- Physical Examination
- Fasting Blood Glucose
- HbA1c
- Blood lipids
- 24h urinary albumin
- Blood Routine Tests
- Urine Routine Tests
- Liver Function Tests
- Renel Function Tests
- Electrocardiogram
- Serum FFA tests
- Treatment of studyed drugs
- Adverse events
Soreness and weakness of waist and knees | Moderate soreness and weakness of waist and knees
|
Lack of sexuality | Hyposexuality
|
Intolerance of cold and cold limbs | Intolerance of cold and cold limbs
|
Mental sluggishness | General
|
Frequent urination at night | Four times at night or more frequent
|
Lower Limbs Edema | Slight Lower Limbs Edema
|
Shortness of breath when moving | Shortness of breath when walking
|
Alopecia and shaken teeth | Mat hair and shaken teeth
|
Tongue characteristics | Light white
|
Tongue coating colour and characters | white tongue coating with water
|
Pause profile | deep, thin, slow
|
Description in detail |
|
Doctor signature | 秦鑫 |
Date | 2017-12-25 yyyy-mm-dd |
Systolic pressure (SP) | 120 mmHg |
Diastolic pressure | 85 mmHg |
Temperature | 36.8 degree Celsius |
Pulse | 78 次/分 |
Breath | 24 次/分 |
Doctor signature | 秦鑫 |
Date | 2017-12-25 yyyy-mm-dd |
Fasting blood glucos concentration | 4.89 mmol/L |
Date of test | 2017-12-25 yyyy-mm-dd |
HbA1c | 5.7 % |
Date of test | 2017-12-25 yyyy-mm-dd |
Triglycerides | 0.6 mmol/L |
Total cholesterol | 2.68 mmol/L |
High density lipoprotein cholesterol | 1.11 mmol/L |
Low density lipoprotein cholesterol | 1.33 mmol/L |
Date of examination | 2017-12-25 yyyy-mm-dd |
24h urinary albumin | 60 mg/24h |
24h urinary microalbumin | 3.5 mg/24h |
Date of test | 2017-12-25 yyyy-mm-dd |
Hb | 141 g/L |
RBC | 4.81 X10*12/L |
WBC | 4.35 X10*9/L |
PLT | 116 X10*9/L |
Neutrophile granulocyte | 66.2 % |
Lymphocyte | 23.7 % |
Date of test | 2017-12-25 |
Urine protein | Negative
|
Urine red cell | Negative
|
Urine WBC | Suspending
|
Urine glucos | Negative
|
KET | Negative
|
SG | 1.007 |
Date of test | 2017-12-25 yyyy-mm-dd |
ALT | 21 IU/L |
AST | 22 IU/L |
Serum albumin | 47.7 g/L |
Date of test | 2017-12-25 yyyy-mm-dd |
SCr | 71 μmol/L |
Blood urea | 4.9 mmol/L |
Blood uric acid | 354 μmol/L |
Estimated glomerular filtration rate ( eGFR) | 84 ml/mim/1.73m*2 |
Date of test | 2017-12-25 yyyy-mm-dd |
ECG | Normal
|
Description for the abnormal findings |
|
Date of examination | 2017-12-25 yyyy-mm-dd |
Serum FFA tests | 无 |
Date of test | 2017-12-25 yyyy-mm-dd |
Date of completing the treatment | 2017-12-25 yyyy-mm-dd |
Weeks of medication | 12 周 |
Adverse events | No
|
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-12-25 yyyymmdd |
Name of adverse event |
|
Reason of adverse event |
|
Start date | yyyymmdd |
Interventions | |
Attribution to study drug | |
Outcome of the event | |
If recovered/resolved, the date is | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-12-25 yyyymmdd |
Date received at DCC | yyyymmdd |
Report type | |
Name of this event |
|
SAE start date | yyyymmdd |
Was this an unanticipated adverse event | |
Attribution to Study Drug | |
Outcome Type(check all that apply) | |
Recovery Description: (check only one) | |
Please provide a brief narrative of the SAE occurrence below |
|
Name of the recorder |
|
Data | yyyymmdd |
Site Investigator’s signature | 秦鑫 |
Data | 2017-12-25 yyyymmdd |
The date of the first medication | 2017-09-24 yyyy-mm-dd |
Date of the last medication | 2017-12-25 yyyy-mm-dd |
Has the participant completed the study per the protocol? | Yes
|
Date of suspended the study | yyyy-mm-dd |
The reason of the suspending | |
Description for the other reason of suspending |
|
Has the participant had completed the site visiting? | |
Date of the last visiting | yyyy-mm-dd |
Reason of suspending | |
Description for other reason of uncomplete the follow-up |
|
Clinical Minitor Statement | / / / / / / / / |
The Monitor signature | 杨明炜 |
Date of signature | 2017-12-25 yyyy-mm-dd |
The Responsible Person (PI) Signature | 陆付耳 |
Date of signature | 2017-12-25 yyyy-mm-dd |